UNSPSC 51191915: Calcium gluconate

This classification denotes an electrolyte replacement agent with the molecular formula 2C6H11O7.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SQE6VB453K, chemically known as gluconic acid, calcium salt but generally known as calcium gluconate, which bears US NIH Compound Identifier 9290. European Medicines Agency schedules Calcium gluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13176MIG.

World Health Organization schedules calcium gluconate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, CALCIUM GLUCONATE remains the US FDA Preferred Term for this commodity. Calcium gluconate bears US NLM identifiers UMLS ID C0006699 and NCI Concept Code C336. SMILES: C(C(C(C(C(C(=O)[O-])O)O)O)O)O.C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[CA+2].

UNSPSC 51191915 Calcium gluconate is a Commodity code that covers pharmaceutical and chemical supply for state and local government facilities, though recent opportunities tagged under this code show mixed relevance—the posting block includes a municipal water treatment chemical (sodium bisulfite) and a multistate cooperative pharmaceutical procurement, neither of which is calcium gluconate specifically. State and local issuing bodies soliciting under this code span municipal utilities, state health and human services departments, and multistate cooperative purchasing alliances administering consolidated buys for multiple jurisdictions. The work itself involves supplying either bulk chemicals for infrastructure operations or pharmaceutical products through authorized distribution networks, with vendors typically evaluated on unit pricing, product compliance (FDA or manufacturing standards), and delivery capability. Procurement structures vary from single-city RFQs to multistate RFP vehicles covering multiple participating states and local entities.

Recent activity appears concentrated in the upper Midwest and Connecticut. The City of Meriden, Connecticut issued RFQ B027-15 for sodium bisulfite chemical supply to its Water Pollution Control Facility, with bids due July 29, 2026, requiring performance and payment bonds and insurance coverage of $1 million to $2 million General Liability. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products to supply participating state and local government facilities including Oregon, with proposals due March 26, 2026; awarded vendors deliver through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC, with contract effectiveness targeted for July 1, 2026. The MMCAP procurement weighted price competitiveness at 75 percent and requires vendors to maintain $5 million commercial general liability and FDA compliance with minimum one-year expiration dates and six-month shelf life on all products.